Document Detail


Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people.
MedLine Citation:
PMID:  22105196     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: High blood pressure (BP) is a risk factor for cerebrovascular disease, including stroke. Little is known about the importance of BP on the progression of microvascular disease of the brain, which has been associated with functional decline in mobility and cognition in older people.
METHODS AND RESULTS: This was a prospective cohort of subjects 75 to 89 years of age to determine relations among vascular risk factors, white matter hyperintensity volume, and functional status. Ninety-nine subjects were enrolled through the use of a balanced 3×3 matrix stratified by age and mobility performance, and 72 subjects completed all sets of baseline and follow-up studies at 2 years. Subjects were excluded if there were medications or systemic or neurological diseases that could compromise mobility. Ambulatory and clinic BP monitoring, magnetic resonance imaging, gait studies, and neuropsychological testing were performed at baseline and after 24 months. Brain classification into normal white matter and T2-hyperintense white matter hyperintensity volume was performed with semiautomated segmentation. Quantitative measures of mobility and cognitive function were obtained longitudinally. Increased ambulatory systolic BP, but not clinic systolic BP, from baseline to 24 month follow-up was associated with increased white matter hyperintensity volume over that same period, as well as measures of executive function/processing speed. Similar associations were observed for 24-hour BP, awake BP, and sleep BP but not for the surge between the sleep and awake time at the 24-month time point.
CONCLUSIONS: These data demonstrate for the first time the importance of 24-hour systolic BP in the progression of brain white matter hyperintensity volume burden associated with impairment of cognitive function in older people. The 24-hour systolic BP may be a potential target for intervention in the elderly to reduce vascular disease of the brain and impairment of function.
Authors:
William B White; Leslie Wolfson; Dorothy B Wakefield; Charles B Hall; Patrick Campbell; Nicola Moscufo; Julia Schmidt; Richard F Kaplan; Godfrey Pearlson; Charles R G Guttmann
Related Documents :
22169436 - The laryngeal mask in infants and children: what is the cuff pressure?
3795356 - Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal ...
21753776 - Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure st...
16482236 - Combined low volume polyethylene glycol solution plus stimulant laxatives versus standa...
18358486 - Discrepancy between increased left ventricular mass and "normal" qrs voltage is associa...
11896036 - Dynamic time course of hemodynamic responses after passive head-up tilt and tilt back t...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Circulation     Volume:  124     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-22     Completed Date:  2012-01-12     Revised Date:  2014-09-13    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2312-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Aging / physiology
Blood Pressure / physiology*
Blood Pressure Monitoring, Ambulatory*
Cerebrovascular Disorders / epidemiology,  physiopathology*
Cognition Disorders / epidemiology,  physiopathology*
Cohort Studies
Disease Progression*
Female
Gait / physiology
Humans
Magnetic Resonance Imaging
Male
Nerve Fibers, Myelinated / pathology
Neuropsychological Tests
Physicians' Offices*
Prospective Studies
Risk Factors
Grant Support
ID/Acronym/Agency:
R01 AG022092/AG/NIA NIH HHS; R01 AG022092/AG/NIA NIH HHS; R01 AG022092-04/AG/NIA NIH HHS; R01 DA024667/DA/NIDA NIH HHS; R01 DA024667/DA/NIDA NIH HHS; R01 DA024667-03/DA/NIDA NIH HHS
Comments/Corrections
Comment In:
Circulation. 2012 Jun 12;125(23):e1017; author reply e1018   [PMID:  22689938 ]
Circulation. 2012 Jun 12;125(23):e1016; author reply e1018   [PMID:  22689937 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dystrophin Dp71: The Smallest but Multifunctional Product of the Duchenne Muscular Dystrophy Gene.
Next Document:  Osteochondral autograft transfer for the treatment of osteochondritis dissecans of the medial femora...